UGT1A1 and Jaundice: The earlier nutrient supplementation occurred well before peak jaundice occurred, allowing time for fortification components to induce intestinal UGT1A1 (opposing the effects of β-glucuronidase) as well as promoting bowel motions—thus enhancing bilirubin excretion and elimination and reducing the enterohepatic recirculation of bilirubin.